In vitro Bioluminescence Used as a Method for Real-Time Inhibition Zone Testing for Antibiotic-Releasing Composites

References (33)

1. 1 Antibiotic-eluting medical devices for various applications [DOI]
2. 2 Carrier Systems for the Local Delivery of Antibiotics in Bone Infections [DOI]
3. 3 Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? [DOI]
4. 4 New approaches for treating staphylococcal biofilm infections [DOI]
5. 5 Antimicrobial Agents in Orthopaedic Surgery [DOI]
6. 6 In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units [DOI]
7. 7 In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals [DOI]
8. 8 Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria [DOI]
9. 9 Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based? [DOI]
10. 10 Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse [DOI]
11. 11 Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits [DOI]
12. 12 Enhancing antibiotic activity: a strategy to control Acinetobacter infections [DOI]
13. 13 Modulation of Salmonella gene expression by subinhibitory concentrations of quinolones [DOI]
14. 14 Lentivirus Immobilization to Nanoparticles for Enhanced and Localized Delivery From Hydrogels [DOI]
15. 15 Real time noninvasive monitoring of contaminating bacteria in a soft tissue implant infection model [DOI]
16. 16 Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds [DOI]
17. 17 An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis [DOI]
18. 18 Escherichia coli K‐12 (pEGFPluxABCDEamp): a tool for analysis of bacterial killing by antibacterial agents and human complement activities on a real‐time basis [DOI]
19. 19 Design of infection-resistant antibiotic-releasing polymers: I. Fabrication and formulation [DOI]
20. 20 Bioluminescent imaging: Emerging technology for non-invasive imaging of bone tissue engineering [DOI]
21. 21 Transcription Modulation of Salmonella enterica Serovar Typhimurium Promoters by Sub-MIC Levels of Rifampin [DOI]
22. 22 Use of a Bioluminescent Pseudomonas aeruginosa Strain within an In Vitro Microbiological System, as a Model of Wound Infection, To Assess the Antimicrobial Efficacy of Wound Dressings by Monitoring Light Production [DOI]
23. 23 A High-Throughput, Homogeneous, Bioluminescent Assay for Pseudomonas aeruginosa Gyrase Inhibitors and Other DNA-Damaging Agents [DOI]
24. 24 Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis [DOI]
25. 25 The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosaassessed by combining antibiotic exposure and bacterial susceptibility [DOI]
26. 26 An Escherichia coli Biosensor Strain for Amplified and High Throughput Detection of Antimicrobial Agents [DOI]
27. 27 The Real-Time-Based Assessment of the Microbial Killing by the Antimicrobial Compounds of Neutrophils [DOI]
28. 28 A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa [DOI]
29. 29 Measurement of Effects of Antibiotics in Bioluminescent Staphylococcus aureus RN4220 [DOI]
30. 30 Innovation in multifunctional bioabsorbable osteoconductive drug-releasing hard tissue fixation devices [DOI]
31. 31 The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials [DOI]
32. 32 Use of Escherichia coli cloned with genes encoding bacterial luciferase for evaluation of chemical toxicity [DOI]
33. 33 Interaction of sub-inhibitory concentrations of ciprofloxacin and rifampicin against Staphylococcus aureus [DOI]

Cited by 6

Showing 4 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Molecular Detection of the Arr-2 Gene in Escherichia coli and Klebsiella pneumoniae Resistant to Rifampicin in Abidjan, Côte D'Ivoire — shares topic coverage
• The Inhibitory Effect of the Combination Treatment of Rifampicin and D-limonene on the Growth and Biofilm Formation of Staphylococcus epidermidis RP62A — shares topic coverage
• Molecular Detection of Mycobacterium tuberculosis Rifampicin Drug Resistance Using rpoB Gene Sequencing in Zimbabwe — shares topic coverage
• Assessing the Impact of Rifampicin on Some Hepatic Parameters of Albino Wistar Rats — shares topic coverage
• Hepatoprotective Activity of Nigella sativa Oil against Antitubercular Drug-induced Hepatotoxicity in Rats — shares topic coverage